Compare SVRA & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | ENVX |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2009 | 2020 |
| Metric | SVRA | ENVX |
|---|---|---|
| Price | $5.30 | $4.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $7.33 | ★ $14.56 |
| AVG Volume (30 Days) | 1.4M | ★ 5.5M |
| Earning Date | 01-01-0001 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $31,821,000.00 |
| Revenue This Year | N/A | $40.85 |
| Revenue Next Year | N/A | $236.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 37.91 |
| 52 Week Low | $1.89 | $4.84 |
| 52 Week High | $7.01 | $16.49 |
| Indicator | SVRA | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 40.47 | 30.07 |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.06 | $8.73 |
| Average True Range (ATR) | 0.31 | 0.37 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 6.42 | 0.94 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.